- VRTX has an average dollar-volume (as measured by average daily share volume multiplied by share price) of $149.9 million.
- VRTX is up 3.6% today from today's close.
EXCLUSIVE OFFER: Get the inside scoop on opportunities in VRTX with the Ticky from Trade-Ideas. See the FREE profile for VRTX NOW at Trade-Ideas More details on VRTX: Vertex Pharmaceuticals Incorporated engages in discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases in specialty markets. Currently there are 8 analysts that rate Vertex Pharmaceuticals a buy, no analysts rate it a sell, and 10 rate it a hold. The average volume for Vertex Pharmaceuticals has been 1.4 million shares per day over the past 30 days. Vertex has a market cap of $32.1 billion and is part of the health care sector and drugs industry. The stock has a beta of 0.99 and a short float of 1.7% with 3.59 days to cover. Shares are up 10.8% year-to-date as of the close of trading on Wednesday. EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.